Search by Drug Name or NDC

    NDC 00093-1135-56 Acitretin 10 mg/1 Details

    Acitretin 10 mg/1

    Acitretin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is ACITRETIN.

    Product Information

    NDC 00093-1135
    Product ID 0093-1135_ba11783f-b2ad-49e8-b3a3-e96d29d1b369
    Associated GPIs 90250510000110
    GCN Sequence Number 019141
    GCN Sequence Number Description acitretin CAPSULE 10 MG ORAL
    HIC3 L1A
    HIC3 Description ANTIPSORIATIC AGENTS,SYSTEMIC
    GCN 13480
    HICL Sequence Number 007827
    HICL Sequence Number Description ACITRETIN
    Brand/Generic Generic
    Proprietary Name Acitretin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acitretin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name ACITRETIN
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091455
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-1135-56 (00093113556)

    NDC Package Code 0093-1135-56
    Billing NDC 00093113556
    Package 30 CAPSULE in 1 BOTTLE (0093-1135-56)
    Marketing Start Date 2013-07-19
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 8.2296
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ACITRETIN 10 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 993a5325-cd10-4450-b5ea-1c0a90510df6 Details

    Revised: 5/2022